BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 38650654)

  • 21. Impaired Human Cardiac Cell Development due to NOTCH1 Deficiency.
    Ye S; Wang C; Xu Z; Lin H; Wan X; Yu Y; Adhicary S; Zhang JZ; Zhou Y; Liu C; Alonzo M; Bi J; Ramirez-Navarro A; Deschenes I; Ma Q; Garg V; Wu JC; Zhao MT
    Circ Res; 2023 Jan; 132(2):187-204. PubMed ID: 36583388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIF-1α Regulates Bone Homeostasis and Angiogenesis, Participating in the Occurrence of Bone Metabolic Diseases.
    Chen W; Wu P; Yu F; Luo G; Qing L; Tang J
    Cells; 2022 Nov; 11(22):. PubMed ID: 36428981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.
    Niborski LL; Gueguen P; Ye M; Thiolat A; Ramos RN; Caudana P; Denizeau J; Colombeau L; Rodriguez R; Goudot C; Luccarini JM; Soudé A; Bournique B; Broqua P; Pace L; Baulande S; Sedlik C; Quivy JP; Almouzni G; Cohen JL; Zueva E; Waterfall JJ; Amigorena S; Piaggio E
    Nat Commun; 2022 Jun; 13(1):3739. PubMed ID: 35768432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance.
    Padeken J; Methot SP; Gasser SM
    Nat Rev Mol Cell Biol; 2022 Sep; 23(9):623-640. PubMed ID: 35562425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H3K9 dimethylation safeguards cancer cells against activation of the interferon pathway.
    Hansen AM; Ge Y; Schuster MB; Pundhir S; Jakobsen JS; Kalvisa A; Tapia MC; Gordon S; Ambri F; Bagger FO; Pandey D; Helin K; Porse BT
    Sci Adv; 2022 Mar; 8(11):eabf8627. PubMed ID: 35302840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUV39H1 regulates corneal epithelial wound healing via H3K9me3-mediated repression of p27.
    Yang S; Chen W; Jin S; Luo G; Jing X; Liu Q; Reinach PS; Qu J; Yan D
    Eye Vis (Lond); 2022 Feb; 9(1):4. PubMed ID: 35101125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H3K9 Methyltransferases Suv39h1 and Suv39h2 Control the Differentiation of Neural Progenitor Cells in the Adult Hippocampus.
    Guerra MV; Cáceres MI; Herrera-Soto A; Arredondo SB; Varas-Godoy M; van Zundert B; Varela-Nallar L
    Front Cell Dev Biol; 2021; 9():778345. PubMed ID: 35096813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chaetocin induced chromatin condensation: effect on DNA repair signaling and survival.
    Sak A; Bannik K; Groneberg M; Stuschke M
    Int J Radiat Biol; 2021; 97(4):494-506. PubMed ID: 33428851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells.
    Shen JZ; Qiu Z; Wu Q; Finlay D; Garcia G; Sun D; Rantala J; Barshop W; Hope JL; Gimple RC; Sangfelt O; Bradley LM; Wohlschlegel J; Rich JN; Spruck C
    Cell; 2021 Jan; 184(2):352-369.e23. PubMed ID: 33357448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reevaluating the roles of histone-modifying enzymes and their associated chromatin modifications in transcriptional regulation.
    Morgan MAJ; Shilatifard A
    Nat Genet; 2020 Dec; 52(12):1271-1281. PubMed ID: 33257899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-520a-3p inhibits malignant progression of epithelial ovarian cancer by targeting SUV39H1 expression.
    Li J; Shao W; Zhao J
    Hum Cell; 2021 Mar; 34(2):570-578. PubMed ID: 33196969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Differentially Methylated Regions Associated with a Knockout of SUV39H1 in Prostate Cancer Cells.
    Yan W; Guo Y; Xu F; Saxena D; Li X
    Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33066102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
    Chu Y; Chen Y; Guo H; Li M; Wang B; Shi D; Cheng X; Guan J; Wang X; Xue C; Cheng T; Shi J; Yuan W
    Oncogene; 2020 Dec; 39(50):7239-7252. PubMed ID: 33037410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal Activation of Hepatitis B Virus-Related Hepatocarcinogenesis by Up-regulation of SUV39h1.
    Takeuchi Y; Tsuge M; Tsushima K; Suehiro Y; Fujino H; Ono A; Yamauchi M; Makokha GN; Nakahara T; Murakami E; Abe-Chayama H; Kawaoka T; Miki D; Imamura M; Aikata H; Hayes CN; Tateno C; Chayama K
    J Infect Dis; 2020 Nov; 222(12):2061-2070. PubMed ID: 32514521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global and regional burdens of oral cancer from 1990 to 2017: Results from the global burden of disease study.
    Ren ZH; Hu CY; He HR; Li YJ; Lyu J
    Cancer Commun (Lond); 2020 Mar; 40(2-3):81-92. PubMed ID: 32067418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF in Signaling and Disease: Beyond Discovery and Development.
    Apte RS; Chen DS; Ferrara N
    Cell; 2019 Mar; 176(6):1248-1264. PubMed ID: 30849371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune Evasion.
    Lu C; Yang D; Klement JD; Oh IK; Savage NM; Waller JL; Colby AH; Grinstaff MW; Oberlies NH; Pearce CJ; Xie Z; Kulp SK; Coss CC; Phelps MA; Albers T; Lebedyeva IO; Liu K
    Cancer Immunol Res; 2019 Mar; 7(3):414-427. PubMed ID: 30610059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.
    Fukumura D; Kloepper J; Amoozgar Z; Duda DG; Jain RK
    Nat Rev Clin Oncol; 2018 May; 15(5):325-340. PubMed ID: 29508855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baicalin hydrate inhibits cancer progression in nasopharyngeal carcinoma by affecting genome instability and splicing.
    Lai W; Jia J; Yan B; Jiang Y; Shi Y; Chen L; Mao C; Liu X; Tang H; Gao M; Cao Y; Liu S; Tao Y
    Oncotarget; 2018 Jan; 9(1):901-914. PubMed ID: 29416665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.